Insider trade

Stryker Corporation (SYK): Director sold ~$7.07M

Ronda E Stryker, Director at Stryker Corporation, sold ~$7.07M of Stryker Corporation shares.

~$7.07M
Approx. value · 20K sh @ $354.13
3.2M
Holds after · shares reported
Traded
Nov 5, 2025
Filed
Nov 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  2. Aug 25, 2025CongressDisclosed partial sale of SYK — reported range $1,001 - $15,000
  3. Sep 12, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  4. Oct 16, 2025CongressDisclosed sale of SYK — reported range $1,001 - $15,000
  5. Oct 17, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  6. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
  7. Nov 5, 2025 · this disclosureInsiderDirector sold ~$7.07M of SYK shares in the open market

What came next

  1. Nov 5, 2025Insider · 1 personInsiders: 6 sales (~$80.0M)
  2. Nov 6, 2025Insider · 1 personInsiders: 7 sales (~$97.6M)
  3. Nov 14, 2025InsiderOfficer sold ~$714K of SYK shares in the open market
  4. Nov 18, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  5. Nov 20, 2025InsiderCFO sold ~$60K of SYK shares in the open market
  6. Nov 20, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  7. Dec 4, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Stryker Corporation (the “Company”) announced on December 4, 2025 that Spencer Stiles, who currently serves as Group President, Orthopaedics, has been appointed President and Chief Operating Officer of the Company effective January 1, 2026.”
  8. Dec 10, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  9. Dec 15, 2025FDAFDA device clearance: Triathlon® Tritanium® Asymmetric Patella; Triathlon® Tritanium® Symmetric Patella; Triathlon® Symmetric Patella; Triathlon® Asymmetric Patella; Scorpio® Univer…
  10. Dec 19, 2025FDAFDA device clearance: Hoffmann LRF System
  11. Dec 31, 2025FDAFDA device clearance: MOLLI 2 System
  12. Jan 13, 2026FDAFDA device clearance: Connected OR Hub with Device and Voice Control; SDC4K Information Management System with Device and Voice Control
  13. Jan 21, 2026FDARecall: MOLLI 2 System System includes: MM1000 (Pack of 10) - MOLLI Introducer (8cm, 14G) and MOLLI Marker UDI (GTIN): 00850024195028 MS-00009 (Pack of 10) - MOLLI Int…
  14. Jan 23, 2026CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  15. Jan 29, 2026Company filing · Form 8-K · ResultsReported its results
  16. Feb 2, 2026FDARecall: MICS3 Angled Sagittal Saw Attachment; Part Number: 210490
  17. Feb 2, 2026InsiderOfficer sold ~$175K of SYK shares in the open market
  18. Feb 3, 2026FDAFDA device clearance: T2 Alpha Femur Retrograde Nailing System; Pangea Femur Reconstruction System
  19. Feb 4, 2026Insider · 1 personInsiders: 11 sales (~$90.7M)
  20. Feb 5, 2026Insider · 1 personInsiders: 7 sales (~$91.0M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Stryker Corporation

For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.

Other recent filings by Ronda E Stryker, Director

The full history of Ronda E Stryker, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Stryker Corporation (SYK) insider traded, and how much?

Ronda E Stryker, Director at Stryker Corporation, sold ~$7.07M of Stryker Corporation shares. 20K shares at $354.13.

When did it happen, and when was it made public?

Traded: Nov 5, 2025. Filed: Nov 7, 2025. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Stryker Corporation recently?

For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days. They are listed on the SYK page.

Does this mean SYK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Stryker Corporation

Everything OQRO holds on this company is on its SYK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data